PARP1 and neoplasm: We demonstratedthat PARPi-MT, a Ru­(II)-based MT incorporating the PARP1inhibitor Olaparib as the binding motif, enables the spatial visualizationof PARP1 in murine brain and xenograft tumor tissues using both DESI-MSIand FI.